Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Jan 24;10(1):1129.
doi: 10.1038/s41598-020-57943-6.

Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles

Affiliations
Comparative Study

Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles

Tânia Lima et al. Sci Rep. .

Abstract

When in contact with biological fluids, nanoparticles dynamically absorb biomolecules like proteins and lipids onto their surface, forming a "corona". This biocorona is a dynamic and complex structure that determines how host cells respond to nanoparticles. Despite the common use of mouse models in pre-clinical and toxicological experiments, the impact of corona formed in mouse serum on the biophysical and biological properties of different size NP has not been thoroughly explored. Furthering the knowledge on the corona formed on NP exposed to mouse serum proteins can help in understanding what role it might have in in vivo studies at systemic, tissue, and cellular levels. To investigate biocorona formation, different sized polystyrene NP were exposed to mouse serum. Our data show a size- and time-dependent protein and lipid corona formation. Several proteins were identified and apolipoproteins were by far the most common group on the NPs surfaces. Moreover, we observed that cholesterol and triglycerides effectively bind to NP emphasizing that proteins are not the only biomolecules with high-affinity binding to nanomaterial surfaces. These results highlight that further knowledge on NP interactions with mouse serum is necessary regarding the common use of this model to predict the in vivo efficiency of NP.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Size distribution of COOH-PS nanoparticles in PBS (black) and MS (blue). Mean by DCS. Measurements were performed by DCS in PBS and 1 h after MS incubation.
Figure 2
Figure 2
Size dependence differences in protein corona of COOH-PS NPs after MS incubation. NPs (200 nm, 80 nm, 26 nm) were incubated at 0,5 mg ml−1 (mass normalized samples) with MS during 1 h, 12 h and 24 h. NP were separated from free proteins by centrifugation and proteins adsorbed to COOH-PS NP was resolved by 10% SDS-Page gel and stained with Coomassie. Full length gel is presented in Supplementary Fig. 6.
Figure 3
Figure 3
Size-dependent differences around COOH-PS NP by SDS-page gel. 200 nm, 80 nm and 26 nm COOH-PS NPs were incubated with MS at 0,5 mg ml−1 or for 1 h at 37 °C. The protein corona was resolved by 10% acrylamide SDS-page gel and a densitometry analysis using Image J/FIJI. A- Myosin-9, B- Clusterin, C- APO E, D- APO A-I. Full lenght gels are presented in Supplementary Figs. 7 and 8.
Figure 4
Figure 4
Venn diagram representing the distribution of proteins found to associate with COOH-PS NP following incubation with MS.
Figure 5
Figure 5
Lipid quantification on COOH-PS NP after MS incubation. Levels of triglycerides and cholesterol in the corona were quantified after 1 h and 24 h incubation with MS in COOH-PS NPs normalized to 5 × 1010 μm2 surface area. (A) Overtime comparison between 200 nm and 80 nm lipid corona. (B) Each condition was set in triplicate. Bars correspond to means plus SD. One-way ANOVA with Bonferroni post Hoc test. (*P < 0,05; **P < 0,01; ****P < 0,0001).

References

    1. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008;3:133–149. doi: 10.2147/IJN.S596. - DOI - PMC - PubMed
    1. Onoue S, Yamada S, Chan HK. Nanodrugs: pharmacokinetics and safety. Int. J. Nanomed. 2014;9:1025–1037. doi: 10.2147/IJN.S38378. - DOI - PMC - PubMed
    1. Mankes RF, Silver CD. Quantitative study of controlled substance bedside wasting, disposal and evaluation of potential ecologic effects. Sci. Total. Env. 2013;444:298–310. doi: 10.1016/j.scitotenv.2012.11.096. - DOI - PubMed
    1. Singh R, Lillard JW., Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009;86:215–223. doi: 10.1016/j.yexmp.2008.12.004. - DOI - PMC - PubMed
    1. Getts DR, Shea LD, Miller SD, King NJ. Harnessing nanoparticles for immune modulation. Trends Immunol. 2015;36:419–427. doi: 10.1016/j.it.2015.05.007. - DOI - PMC - PubMed

Publication types